Sartorius Stedim Biotech Share Price
Equities
DIM
FR0013154002
Medical Equipment, Supplies & Distribution
|
Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
| 165.75 EUR | -2.59% |
|
-9.50% | -21.10% |
| 06:03pm | RBC Capital Upgrades Sartorius Stedim Biotech to Outperform Rating, Reduces PT | MT |
| 12:59pm | SARTORIUS STEDIM BIOTECH : Raised to Buy by RBC | ZD |
| Capitalization | 1.66TCr 1.91TCr 1.5TCr 1.44TCr 2.63TCr 1,75800Cr 2.74TCr 18TCr 7.09TCr 84TCr 7.18TCr 7.03TCr 3,02000Cr | P/E ratio 2026 * |
40.1x | P/E ratio 2027 * | 31.2x |
|---|---|---|---|---|---|
| Enterprise value | 1.86TCr 2.15TCr 1.68TCr 1.62TCr 2.95TCr 1,97300Cr 3.08TCr 20TCr 7.95TCr 95TCr 8.06TCr 7.89TCr 3,38900Cr | EV / Sales 2026 * |
5.83x | EV / Sales 2027 * | 5.15x |
| Free-Float |
30.28% | Yield 2026 * |
0.52% | Yield 2027 * | 0.68% |
Last Transcript: Sartorius Stedim Biotech
| 1 day | -2.62% | ||
| 1 week | -9.50% | ||
| Current month | -9.50% | ||
| 1 month | -6.86% | ||
| 3 months | -21.65% | ||
| 6 months | -4.85% | ||
| Current year | -21.10% |
| 1 week | 165.4 |  | 180.55 |
| 1 month | 165.4 | | 185 |
| Current year | 165.4 | | 224 |
| 1 year | 148.75 | | 224 |
| 3 years | 139.1 | | 321.1 |
| 5 years | 139.1 | | 551 |
| 10 years | 50.1 | | 551 |
| Manager | Title | Age | Since |
|---|---|---|---|
René Fáber
CEO | Chief Executive Officer | 50 | 28/03/2023 |
| Chief Tech/Sci/R&D Officer | 61 | 08/09/2011 | |
Petra Kirchhoff
IRC | Investor Relations Contact | 57 | - |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 64 | 07/04/2015 | |
Susan Dexter
BRD | Director/Board Member | 69 | 07/04/2015 |
Lothar Kappich
BRD | Director/Board Member | 69 | 14/09/2017 |
| Name | Varia. Jan 1. | Weight | AuM | |
|---|---|---|---|---|
 | -1.01% | 0.42% | 26 M€ |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -2.59% | -9.50% | -15.91% | -46.96% | 1.91TCr | |
| -1.81% | -4.49% | -19.37% | +6.31% | 19TCr | |
| -2.02% | -4.14% | -1.12% | +11.51% | 12TCr | |
| -0.31% | -2.01% | +42.84% | +130.09% | 6.99TCr | |
| +1.31% | +0.87% | +61.53% | +102.20% | 6.01TCr | |
| -2.02% | -3.80% | -24.17% | -28.36% | 4.84TCr | |
| -1.42% | -9.90% | - | - | 3.58TCr | |
| -2.24% | -4.96% | -13.75% | -42.49% | 2.72TCr | |
| -2.32% | -6.36% | +4.87% | +25.56% | 2.34TCr | |
| +4.33% | -2.32% | -26.22% | +13.49% | 1.85TCr | |
| Average | -0.93% | -4.64% | +0.97% | +19.04% | 6.15TCr | |
| Weighted average by Cap. | -1.28% | -4.33% | +1.04% | +26.33% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 318.81Cr 368.66Cr 288.7Cr 277.17Cr 505.53Cr 34TCr 527.81Cr 3.42TCr 1.36TCr 16TCr 1.38TCr 1.35TCr 58TCr | 354.96Cr 410.45Cr 321.43Cr 308.6Cr 562.84Cr 38TCr 587.65Cr 3.8TCr 1.52TCr 18TCr 1.54TCr 1.51TCr 65TCr |
| Net income | 41Cr 48Cr 37Cr 36Cr 65Cr 4.38TCr 68Cr 442.14Cr 176.67Cr 2.1TCr 179.11Cr 175.28Cr 7.53TCr | 52Cr 60Cr 47Cr 45Cr 82Cr 5.5TCr 86Cr 555.13Cr 221.83Cr 2.64TCr 224.88Cr 220.08Cr 9.45TCr |
| Net Debt | 202.2Cr 233.82Cr 183.1Cr 175.79Cr 320.62Cr 21TCr 334.76Cr 2.17TCr 865.64Cr 10TCr 877.56Cr 858.81Cr 37TCr | 172.61Cr 199.6Cr 156.31Cr 150.06Cr 273.7Cr 18TCr 285.76Cr 1.85TCr 738.94Cr 8.78TCr 749.12Cr 733.12Cr 31TCr |
| Date | Price | Change | Volume |
|---|---|---|---|
| 06/26/06 | 165.75 € | -2.59% | 16,144 |
| 05/26/05 | 170.15 € | -2.63% | 73,504 |
| 04/26/04 | 174.75 € | +4.61% | 81,428 |
| 03/26/03 | 167.05 € | -7.04% | 1,41,055 |
| 02/26/02 | 179.70 € | -1.86% | 1,04,785 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- DIM Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition